Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines
about
Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Morbidity, mortality and cost ...... f 2-, 4- and 9-valent vaccines
@en
Morbidity, mortality and cost ...... 2-, 4- and 9-valent vaccines.
@nl
type
label
Morbidity, mortality and cost ...... f 2-, 4- and 9-valent vaccines
@en
Morbidity, mortality and cost ...... 2-, 4- and 9-valent vaccines.
@nl
prefLabel
Morbidity, mortality and cost ...... f 2-, 4- and 9-valent vaccines
@en
Morbidity, mortality and cost ...... 2-, 4- and 9-valent vaccines.
@nl
P2093
P2860
P1476
Morbidity, mortality and cost ...... f 2-, 4- and 9-valent vaccines
@en
P2093
Michael Moore
Vikas Mehta
P2860
P304
P356
10.1080/21645515.2015.1095415
P407
P577
2015-11-13T00:00:00Z